Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (2024)

Table of Contents
LH US5049221055 Business description: Labcorp Holdings Inc. Sales by Activity: Labcorp Holdings Inc. Geographical breakdown of sales: Labcorp Holdings Inc. Managers: Labcorp Holdings Inc. Members of the board: Labcorp Holdings Inc. Company details: Labcorp Holdings Inc. Group companies: Labcorp Holdings Inc. Other Healthcare Facilities & Services Sector Ratings Analysts' Consensus Quarterly earnings, Rate of surprise Income Statement and Estimates FAQs

LABCORP HOLDINGS INC.

Add to a list

To use this feature you must be a member

Log inSign up

Equities

LH

US5049221055

Market Closed - Nyse

Other stock markets

 04:00:02 2024-08-30 pm EDT 		5-day change 1st Jan Change
229.89 USD +0.09% Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (2) -0.43% +1.14%
Aug. 21 Labcorp Holdings Insider Sold Shares Worth $454,100, According to a Recent SEC Filing MT
Aug. 21 JPMorgan Adjusts Price Target on Labcorp Holdings to $271 From $243, Maintains Overweight Rating MT

Business description: Labcorp Holdings Inc.

Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (3)

Labcorp Holdings Inc. provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.

Number of employees: 61,975

Sales by Activity: Labcorp Holdings Inc.

Fiscal Period: December20192020202120222023

Diagnostics

7B 9.25B 10.36B 9.2B 9.42B

Biopharma Laboratory Services

4.58B 4.88B 5.85B 5.71B 2.77B

Intercompany Eliminations and Other

-23.4M -153M -88.2M -36.9M -27.7M

See all business segments

Geographical breakdown of sales: Labcorp Holdings Inc.

Fiscal Period: December20192020202120222023

United States

8.98B - - 11.53B 10.18B

North America (Excl. United States)

- - - 2.68B 1.73B

Europe

- 1.51B 2.05B 435M 179M

Other

1.2B 941M 976M 234M 79.36M

North America

- 11.53B 13.09B - -

Switzerland

533M - - - -

United Kingdom

508M - - - -

Canada

333M - - - -

See all geographic segments

Managers: Labcorp Holdings Inc.

Director TitleAgeSince

Adam Schechter CEO

 Chief Executive Officer 59 13-03-31

Glenn Eisenberg DFI

 Director of Finance/CFO 62 14-06-15

Sandra van der Vaart CMP

 Compliance Officer 65 19-01-31

Geraldine McDowell CTO

 Chief Tech/Sci/R&D Officer - -

Lance Berberian CTO

 Chief Tech/Sci/R&D Officer 61 14-01-31

See LABCORP HOLDINGS INC. governance

Members of the board: Labcorp Holdings Inc.

Manager TitleAgeSince

Kerrii Anderson BRD

 Director/Board Member 66 06-05-16

Peter Neupert BRD

 Director/Board Member 68 12-12-31

Adam Schechter CEO

 Chief Executive Officer 59 13-03-31

Garheng Kong BRD

 Director/Board Member 49 13-11-30

D. Gilliland BRD

 Director/Board Member 69 14-03-31

Richelle Parham BRD

 Director/Board Member 56 16-02-07

Jeffrey Davis BRD

 Director/Board Member 60 19-11-30

Kathryn Wengel BRD

 Director/Board Member 58 21-03-24

Kirsten Kliphouse BRD

 Director/Board Member 57 22-10-11

Paul Rothman BRD

 Director/Board Member 65 23-06-05

Composition of the Board of Directors

Company details: Labcorp Holdings Inc.

Laboratory Corp. of America Holdings

358 South Main Street

27215-5837, Burlington

+336 229 1127

http://www.labcorp.com

Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (4)

Group companies: Labcorp Holdings Inc.

NameCategory and Sector

Fortrea UK Holdings Ltd.

Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (5)

Fortrea UK Holdings Ltd.

Financial ConglomeratesFinance

Part of Fortrea Holdings, Inc., Fortrea UK Holdings Ltd. is an investment holding company. Fortrea UK Holdings Ltd. is based in Harrogate, UK. Founded in 1991.

Financial Conglomerates

Labcorp Early Development Laboratories Ltd.

Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (6)

Labcorp Early Development Laboratories Ltd.

Miscellaneous Commercial ServicesCommercial Services

Part of Fortrea Holdings, Inc., Labcorp Early Development Laboratories Ltd. is a British company that provides early-stage and late-stage product development services. The company is based in Harrogate, UK. Labcorp Early Development Laboratories was founded in 1974.

Miscellaneous Commercial Services

Fortrea Development Ltd.

Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (7)

Fortrea Development Ltd.

Miscellaneous Commercial ServicesCommercial Services

Part of Fortrea Holdings, Inc., Fortrea Development Ltd. is a British company that provides clinical development services. The company is based in Maidenhead, UK.

Miscellaneous Commercial Services

Labcorp International Holdings BV

COVANCE INC.

Pharmaceuticals: Major

See all subsidiaries

Other Healthcare Facilities & Services

Add to a list

Add to a list

0 selected

To use this feature you must be a member

Log inSign up

 Change 5d. change 1-year change 3-years change Capi. ($)

LABCORP HOLDINGS INC.

+0.09%-0.43%+10.47%-24.22% 19.3B

HCA HEALTHCARE, INC.

+0.71%+1.75%+42.66%+56.37% 102B

CVS HEALTH CORPORATION

+0.47%-2.57%-12.17%-33.74% 72.01B

DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY

+0.79%-0.91%+25.93%+66.67% 28.54B

+0.39%+1.58%+12.70%-24.25% 20.79B

QUEST DIAGNOSTICS INCORPORATED

+0.47%+2.22%+19.37%+2.71% 17.47B

TENET HEALTHCARE CORPORATION

+0.71%+0.80%+113.82%+120.09% 15.89B

UNIVERSAL HEALTH SERVICES, INC.

+0.97%+2.07%+76.67%+52.78% 15.88B

NATERA, INC.

+1.73%-3.63%+101.36%-0.14% 14.63B

REDE D'OR SÃO LUIZ S.A.

-1.72%-4.89%+11.41%-53.60% 12.67B
Average +0.46%-0.40%+40.22%+16.27% 31.93B
Weighted average by Cap. +0.55%-0.12%+30.31%+19.95%

See all sector performances

Sector

Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (18) Healthcare
Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (19) Healthcare Services
Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (20)
Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (21)
Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (22)

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

B

More Ratings

Analysts' Consensus

Sell

Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (23)

Buy

Mean consensus

OUTPERFORM

Number of Analysts

17

Last Close Price

229.89USD

Average target price

250.13USD

Spread / Average Target

+8.81%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Income Statement and Estimates

More financial data

  1. Stock Market
  2. Equities
  3. LH Stock
  4. Company Labcorp Holdings Inc.
Our Free Content Help you Secure and Increase the Performance of Your Investments Secure my Investments

Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (24)

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '13392');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });
Labcorp Holdings Inc.: Shareholders Board Members Managers and Company Profile | US5049221055 | MarketScreener (2024)

FAQs

Who are the shareholders of Labcorp? ›

Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, Wellington Management Group Llp, Geode Capital Management, Llc, Diamond Hill Capital Management Inc, Jpmorgan Chase & Co, Bank of New York Mellon Corp, Allspring Global Investments Holdings, LLC, and Dimensional Fund Advisors Lp .

Learn More Now ›
What is the company profile of Labcorp? ›

Labcorp is a leading global life sciences company. With a mission to improve health and improve lives, Labcorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.

Explore More ›
How big of a company is Labcorp? ›

A leading global life sciences company

The company's more than 67,000 employees serve clients in over 100 countries, worked on over 84% of the new drugs approved by the FDA in 2023 and performed more than 600 million tests for patients around the world.

Discover More ›
Is Labcorp a publicly traded company? ›

Laboratory Corporation of America® Holdings is listed on the New York Stock Exchange under the symbol LH.

Show Me More ›
Who is the CEO of Labcorp headquarters? ›

Adam Schechter became chief executive officer of Labcorp (NYSE: LH) in November 2019 and chairman in May 2020. Previously, Schechter was named lead independent director in January 2019 after serving on the board since 2013.

Tell Me More ›
Who did Labcorp merge with? ›

Upon full integration, providers and patients in Northern California and Orange County who previously received lab service from Providence will have access to Labcorp's clinical lab services, data and digital tools, according to the release.

Read More ›
What is the turnover of Labcorp? ›

According to LabCorp's latest financial reports the company's current revenue (TTM ) is ₹1.047 T. In 2023 the company made a revenue of ₹1.012 T a decrease over the revenue in the year 2022 that were of ₹1.105 T. The revenue is the total amount of income that a company generates by the sale of goods or services.

Learn More ›
What is the new name for Labcorp? ›

9, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development business will be known as Fortrea.

See Details ›
Where is LabCorp's main headquarters? ›

Find Out More ›
How profitable is LabCorp? ›

Burlington, North Carolina-based Labcorp's total sales came in at $3.22 billion, topping estimates of $3.19 billion. On an adjusted basis, Labcorp reported a second-quarter profit of $3.94 per share, beating estimates of $3.78 per share.

Find Out More ›

Who is bigger Quest or LabCorp? ›

Over the years, the two largest commercial clinical diagnostic laboratory companies in the U.S., and probably the world, have been Laboratory Corporation of America known as LabCorp, and Quest Diagnostics. For years, Quest was the largest, but LabCorp took over that spot a few years ago.

Discover More Details ›
What is the new holding company structure of Labcorp? ›

The name of the new holding company will be Labcorp Holdings Inc. The new parent company will replace Laboratory Corporation of America Holdings as the publicly traded entity and Laboratory Corporation of America Holdings will become a wholly owned subsidiary of Labcorp Holdings Inc.

Read More ›
Is Labcorp a good stock to buy? ›

Laboratory Corporation Of America Holdings has a consensus rating of Moderate Buy which is based on 8 buy ratings, 3 hold ratings and 0 sell ratings.

Tell Me More ›
Who competes with Labcorp? ›

Labcorp competitors include IQVIA, Thermo Fisher Scientific and Quest Diagnostics.

Learn More ›
Labcorp - WikipediaWikipediahttps://en.wikipedia.org ›

Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American healthcare company headquartered in Burlington, North Carolina. It op...
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patient...
Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below....

Read More ›
Who is bigger LabCorp or quest? ›

Over the years, the two largest commercial clinical diagnostic laboratory companies in the U.S., and probably the world, have been Laboratory Corporation of America known as LabCorp, and Quest Diagnostics. For years, Quest was the largest, but LabCorp took over that spot a few years ago.

Explore More ›
Does Roche own LabCorp? ›

Corporate governance. As of December 2013, the Labcorp Board of Directors includes Garheng Kong. In 1997 Roche owned 49.7% of Labcorp but sold all of their Labcorp stock as of late 2002.

Get More Info Here ›
Who is the head of LabCorp? ›

Adam Schechter serves as the CEO / President of Labcorp. Katherine Pregel serves as the Director, Government Relations and Public Policy for LabCorp. Katherine started at... Amy Rhine-Pallas serves as the Senior Vice President of Labcorp.

Get More Info Here ›
Why did LabCorp buy Covance? ›

The deal enables LabCorp to diversify its customer base away from insurers and to squeeze more revenue from its extensive patient health data, executives said. LabCorp said it would pay Covance shareholders about $75.76 in cash, and 0.2686 LabCorp shares, for each Covance share.

Know More ›
Top Articles
So verwenden Sie Keyframes in CapCut
How to Add Keyframes in CapCut on PC & Mobile
SUMMER MUSIC FESTIVALS: Get outside and soak up tunes
Read Prince Harry’s written statement. (Published 2023)
Shahreza Bakery
Violent Night Showtimes Near Amc Marquis 16
Leni Klum: Alles zum Sprössling von Heidi Klum
Leni Klum: Steckbrief, News und Bilder | Promipool
1636 - Pokemon Fire Red (U)(Squirrels).GBA: A Deep Dive into Gaming History - Def Startup
Pokemon FireRed ROM Hacks List | PokemonCoders
Burger King Foot Lettuce Copypasta
Groupon Meow Wolf Denver
Latest Posts
A Comprehensive Guide to Mastering CapCut's Keyframe Animation - The Plaid Horse Magazine
Minden reggel hajnali 5-kor kelek, így változott meg az életem
Article information

Author: Saturnina Altenwerth DVM

Last Updated:

Views: 6303

Rating: 4.3 / 5 (64 voted)

Reviews: 87% of readers found this page helpful

Author information

Name: Saturnina Altenwerth DVM

Birthday: 1992-08-21

Address: Apt. 237 662 Haag Mills, East Verenaport, MO 57071-5493

Phone: +331850833384

Job: District Real-Estate Architect

Hobby: Skateboarding, Taxidermy, Air sports, Painting, Knife making, Letterboxing, Inline skating

Introduction: My name is Saturnina Altenwerth DVM, I am a witty, perfect, combative, beautiful, determined, fancy, determined person who loves writing and wants to share my knowledge and understanding with you.